Celestica (CLS) Tops Q1 EPS by 14c

Celestica (NYSE: CLS) reported Q1 EPS of $0.86, $0.14 better than the analyst estimate of $0.72. Revenue for the quarter came in at $2.21 billion versus the consensus estimate of $2.1 billion.

For earnings history and earnings-related data on Celestica (CLS) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
• Paramount Global (PARA) Tops Q2 EPS by 480c